Tracheostomy products Market Size

Global Tracheostomy Products Market Overview

Tracheostomy Products Market Size was valued at USD 0.15 Billion in 2022. The Tracheostomy Products market industry is projected to grow from USD 0.16 Billion in 2023 to USD 0.24 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.40% during the forecast period (2023 - 2032). Increasing demand for intensive and rising road accidents are the key market drivers enhancing the growth of the studied market.

Source Secondary Research, Primary Research, MRFR Database, and Analyst Review

Tracheostomy Products Market Trends

• Rise in respiratory diseases are driving the market growth

The growing cases of chronic respiratory diseases are driving Market CAGR for Tracheostomy Products. The rise in the prevalence of long-term respiratory conditions such cancer, cardiovascular diseases (CVDs), diabetes, and other respiratory ailments. In addition, as more procedures are conducted ly, there is a continuing rise in the demand for tracheostomy accessories. One of the main causes of death worldwide is COPD. Over 251 million individuals suffered from COPD worldwide in 2016, according to the WHO.

One of the main causes of the rise in COPD prevalence and subsequent rise in the need for tracheostomy care is the rising prevalence of tobacco use and poor air quality, especially in middle-income countries. The number of patients requiring mechanical ventilation, as well as respiratory help, has significantly grown as a result of the COVID-19 epidemic. While some of these patients need tracheostomies to enable weaning and better utilisation of hospital resources, many of these patients require mechanical ventilation for an extended period of time. The creation of aerosols and the considerable danger of nosocomial transmission to medical staff make the tracheostomy procedure challenging to execute. Despite being the standard of care in many ICUs, percutaneous tracheostomy (PCT) has a higher risk of generating aerosols than surgical tracheostomy.

Tracheostomy, however, serves the purpose of helping COVID-19 patients wean. It is anticipated that rising healthcare costs and the economies of countries like the U.S., China, and India, among others, will offer lucrative opportunities for industry players. Additionally, tracheostomy items are used in tracheostomy treatments for a variety of conditions, such as obstructive sleep apnea, chronic lung disease, anaphylaxis, throat cancer, coma, diaphragm dysfunction, laryngectomy, and vocal cord paralysis. Due to favorable reimbursement regulations, a growing healthcare infrastructure, and a high frequency of respiratory disorders, the market is expected to expand. Thus, driving the Tracheostomy Products market revenue.

In February 2024, a Swedish medtech company called Capitainer, which aims to provide intelligent answers for self-testing of blood and plasma, became a Society portfolio company and received a SEK 30 mln investment from We Venture Capital, the venture capital branch of Werfen Group. This significant development will be instrumental in this new phase as Capitainer aims to become one of the key suppliers of self-sampling solutions.

In September 2023, 2San partnered with Phoenix Healthcare in order to launch self-diagnostic tests in the UK. At first, there will be five types available at 380 Rowlands pharmacy outlets, then on September 1st ten samples were sent out to 5,200 independent members of Numark nationwide.

On November 2022, Tracheostomy tubes shortage had been notified by U.S. FDA to patients/caregivers/healthcare providers, including Bivona tracheostomy tubes made by ICU Medical, which are running low. Moreover, the FDA revealed that infants were prone to suffer the most due to the extremely limited availability of alternative tube types having similar functionalities as the Bivona type.

Tracheostomy Products Market Segment Insights

Tracheostomy Products Product Type Insights

The Tracheostomy Products market segmentation, based on the product type, is segmented into Tracheostomy tubes, Cannula, Tracheostomy clean and care kits, and Other Accessories. The market was led by the tracheostomy tubes segment because these tubes are widely used in tracheostomy procedures for a variety of conditions, including anaphylaxis, chronic respiratory disease, coma, esophageal cancer, laryngectomy, sleep apnea, vocal cord paralysis, and diaphragm dysfunction. Significant benefits of tracheostomy tubes include enhanced ventilation, exact accuracy, decreased risk of emissions and aspiration, elimination of intubations, and laryngoscopies.

Tracheostomy Products Material Insights

Based on the material of Tracheostomy Products, the Tracheostomy Products market segmentation includes Polyvinyl chloride, Silicone, and Others. The category with the biggest share and the quickest projected CAGR during the projection period is silicone. Patients who can protect their airways, have a strong enough cough reflex, and most critically, can control their secretions, are typically the ones who use these tubes. With the simultaneous use of a speaking valve, they may improve swallowing and communication by eliminating the danger of tracheal injury from cuff inflation.

Tracheostomy Products End-User Insights

The Tracheostomy Products market segmentation, based on end-user, includes Hospitals & clinics, Ambulatory surgery centers, and Others. The segment of hospitals and clinics dominated the world market. This expansion was related to hospitals' ability to afford pricey goods and equipment. Additionally, tracheostomy items are frequently used in operating rooms, emergency rooms, and critical care facilities. 

Figure 1 Tracheostomy Products Market, by end-user, 2022 & 2032 (USD Billion)

Source Secondary Research, Primary Research, MRFR Database, and Analyst Review

Tracheostomy Products Regional Insights

By region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. During the projected period, the North American Tracheostomy Products market is expected to dominate over the course of the forecasted period. This is a result of the quick development of novel treatments and technology for throat cancer, the escalating presence of important actors in the area, and the advancement of the healthcare system. Several key reasons, including increased healthcare spending per person and a high prevalence of respiratory disorders, also contribute to the market's expansion.

Further, the major countries studied in the market report are The US, Canada, German, France, the U.K., Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2 TRACHEOSTOMY PRODUCTS MARKET SHARE BY REGION 2022 (USD Billion)

Source Secondary Research, Primary Research, MRFR Database, and Analyst Review

Asia Pacific Tracheostomy Products market accounts for the fastest market. Due to the Asia Pacific region's highly populated and polluted nations, which contribute to an increase in respiratory disorders, the region has experienced rapid expansion. Moreover, the China Tracheostomy Products market held the largest market share, and the India Tracheostomy Products market was the quickest-growing market in the Asia-Pacific region.

The Europe Tracheostomy Products Market is expected to expand at the quickest CAGR from 2023 to 2032. This is due to the region's growing geriatric population and the rising launch of a variety of technologically sophisticated tracheostomy solutions. Additionally, the region's growth is being boosted by the rising popularity of home healthcare in the area. Further, the Canada Tracheostomy Products market was the fastest-growing region in the market, and the German Tracheostomy Products market held a substantial share of the market.

Tracheostomy Products Key Market Players & Competitive Insights

Leading market players are investing capital and resources across research and development to extend their product offerings, this is expected to help the Tracheostomy Products market, grow even more. Market leaders and manufacturers are also adopting various strategies to expand their worldwide footprint, with important market developments including new product developments & launches, contracts & agreements, mergers & acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, the Tracheostomy Products industry must offer cost-effective items.

The manufacturers are making use of locally available resources to minimize the production costs which will aid the growth of the  Tracheostomy Products industry to benefit clients and increase the market sector. In recent years, the Tracheostomy Products industry has offered some of the most significant advantages to medicine. Major players in the Tracheostomy Products Market, including Pulmozyme, Troge Medical GmbH, Boston Medical Products Inc., Fuji Systems Corporation, Fisher & Paykel Healthcare Ltd, Teleflex Incorporated, Medtronic PLC, Smiths Group PLC, TRACOE Medical GmbH, and others, are attempting to increase market demand by investing in research and development operations.

Critical care and surgical disposable medical technology products are designed, developed, produced, and distributed by Teleflex Inc. (Teleflex). The primary goods produced by the company include endotracheal tubes, pain pumps, supraglottic airways, circuits, masks and bags, catheters, adaptors, and connectors. Its products are used in specialties such as surgery, anesthesia, cardiac care, urology, emergency medicine, and respiratory care. They also have applications in vascular and interventional access. Through its internal sales team, independent salespeople, and independent distributor networks, Teleflex sells its products to hospitals, healthcare facilities, distributors, and original equipment manufacturers. Operating regions for the company include the Americas, Europe, the Middle East, Africa, and Asia. Wayne, Pennsylvania, in the US, is home to Teleflex's headquarters. In June 2023, A  recall of the recalled batches of the following Rüsch Endotracheal Tube products has been announced by Teleflex Incorporated. To manage the patient's airway, the Rüsch Endotracheal Tube devices are approved for oral or nasal intubation. Endotracheal tubes are inserted inside the trachea with the help of stylets.

Imaging systems, material solutions, and healthcare solutions are all produced by Fujifilm Holdings Corp. (Fujifilm). The business provides document solutions, including office supplies, printers for the workplace, allied production services, and international services. The company's main goods are color films, color paper and chemicals, photofinishing tools, electronic imaging and optical equipment, TV cameras, security lenses, healthcare items, graphic systems, flat panel display components, recording media, and industrial goods. Additionally, Fujifilm provides supplies and equipment for pharmaceuticals, cosmetics, and dietary supplements. Both individual consumers and commercial entities are served by the corporation. In February 2023, At the third annual conference on Interventional Pulmonology - "BRONCHUS 2023," FUJIFILM India announced the addition of the new compact ultrasonic probe system PB2020-M2 to its line of endoscopic products. All of the top pulmonologists from 18 different nations attended the two-day conference in Hyderabad, where FUJIFILM India displayed its extensive line of pulmonology solutions through a one-of-a-kind "Experience center" at the trade expo

Key Companies in the Tracheostomy Products market include

• Pulmozyme,


• Troge Medical GmbH,


• Boston Medical Products Inc.,


• Fuji Systems Corporation,


• Fisher & Paykel Healthcare Ltd,


• Teleflex Incorporated,


• Medtronic PLC,


• Smiths Group PLC,


• TRACOE Medical GmbH

Tracheostomy Products Industry Developments

August 2021 The EXALT Model B Single-Use Bronchoscope, manufactured by Boston Scientific Corporation for use in procedures of bedside in the intensive care unit (ICU) and operating room (OR), has received FDA 510(k) approval.

November 2022 Patients, carers, and healthcare professionals have been informed by the U.S. FDA that there is a scarcity of tracheostomy tubes, particularly Bivona tracheostomy tubes made by ICU Medical. Furthermore, the FDA noted that due to a lack of substitute tubes with comparable performance, the shortage of Bivona tracheostomy tubes is more likely to impact pediatric patients.

Tracheostomy Products Market Segmentation

Tracheostomy Products, Product Type Outlook (USD Billion, 2018-2032)

• Tracheostomy tubes


• Cannula


• Tracheostomy cleaning and care kits


• Other Accessories

Tracheostomy Products, Material Outlook (USD Billion, 2018-2032)

• Polyvinyl chloride


• Silicone


• Others

Tracheostomy Products, End-users Outlook (USD Billion, 2018-2032)

• Hospitals & clinics


• Ambulatory surgery centers


• Others

Tracheostomy Products Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America